BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 22
• 23
• 26
• 27
• 28
• 29
• 30

• Press Releases

  PeproMene Bio announced study demonstrating strong polyfunctionality of novel chimeric antigen receptor (CAR) T cells

  August 8, 2024

   · 

  4 min read
• Press Releases

  RadNet Reports Second Quarter Financial Results with Record Quarterly Revenue and Adjusted EBITDA(1) and Revises Upwards 2024 Financial Guidance Ranges

  August 8, 2024

   · 

  29 min read
• Press Releases

  Eyenovia and Formosa Pharmaceuticals Initiate Co-Development of Clobetasol Propionate Ophthalmic Suspension (0.05%) for the Treatment of Acute Dry Eye Disease in the U.S.

  August 8, 2024

   · 

  5 min read
• Press Releases

  IMUNON to Hold Second Quarter 2024 Financial Results and Business Update Conference Call on Wednesday, August 14, 2024

  August 8, 2024

   · 

  3 min read
• Press Releases

  Eupraxia Pharmaceuticals Reports Second Quarter 2024 Financial Results

  August 8, 2024

   · 

  11 min read
• Press Releases

  CENTOGENE Receives Delisting Notice From Nasdaq

  August 8, 2024

   · 

  5 min read
• Press Releases

  Novartis receives FDA accelerated approval for Fabhalta® (iptacopan), the first and only complement inhibitor for the reduction of proteinuria in primary IgA nephropathy (IgAN)

  August 8, 2024

   · 

  12 min read
• Press Releases

  Bavarian Nordic Receives USD 156.8 Million from the U.S. Government for Additional Smallpox/Mpox Vaccine Production

  August 8, 2024

   · 

  5 min read
• Press Releases

  Evotec Announces Progress in Strategic Neuroscience Partnership with Bristol Myers Squibb

  August 8, 2024

   · 

  4 min read
• Press Releases

  Recursion updates L(earnings) call on August 8th to 8:30 am ET / 6:30 am MT

  August 8, 2024

   · 

  3 min read